BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3999002)

  • 21. Effects of solvent polarity on the acid dissociation constants of benzoic acids.
    Rubino JT; Berryhill WS
    J Pharm Sci; 1986 Feb; 75(2):182-6. PubMed ID: 3958930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solvent effects on chemical processes. 11. Solvent effects on the kinetics of decarboxylative dechlorination of N-chloro amino acids in binary aqueous-organic solvents.
    LePree JM; Connors KA
    J Pharm Sci; 1996 Jun; 85(6):560-6. PubMed ID: 8773949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent.
    Kawakami K; Miyoshi K; Ida Y
    J Pharm Sci; 2004 Jun; 93(6):1471-9. PubMed ID: 15124205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catalytic activity and denaturation of enzymes in water/organic cosolvent mixtures. Alpha-chymotrypsin and laccase in mixed water/alcohol, water/glycol and water/formamide solvents.
    Mozhaev VV; Khmelnitsky YL; Sergeeva MV; Belova AB; Klyachko NL; Levashov AV; Martinek K
    Eur J Biochem; 1989 Oct; 184(3):597-602. PubMed ID: 2806243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action.
    Yamane MA; Williams AC; Barry BW
    J Pharm Pharmacol; 1995 Dec; 47(12A):978-89. PubMed ID: 8932680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubility enhancement of a bisnaphthalimide tumoricidal agent, DMP 840, through complexation.
    Raghavan KS; Nemeth GA; Gray DB; Hussain MA
    Pharm Dev Technol; 1996 Oct; 1(3):231-8. PubMed ID: 9552305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended Hildebrand Solubility Approach: methylxanthines in mixed solvents.
    Martin A; Paruta AN; Adjei A
    J Pharm Sci; 1981 Oct; 70(10):1115-20. PubMed ID: 7299644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solvent effects on chemical processes. I: Solubility of aromatic and heterocyclic compounds in binary aqueous-organic solvents.
    Khossravi D; Connors KA
    J Pharm Sci; 1992 Apr; 81(4):371-9. PubMed ID: 1308660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended Hildebrand solubility approach and the log linear solubility equation.
    Martin A; Wu PL; Adjei A; Lindstrom RE; Elworthy PH
    J Pharm Sci; 1982 Aug; 71(8):849-56. PubMed ID: 7120084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solubility of nonelectrolytes in polar solvents III: Alkyl p-aminobenzoates in polar and mixed solvents.
    Yalkowsky SH; Amidon GL; Zografi G; Flynn GL
    J Pharm Sci; 1975 Jan; 64(1):48-52. PubMed ID: 1133705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of drug precipitation upon dilution of pH-cosolvent solubilized formulations.
    Narazaki R; Sanghvi R; Yalkowsky SH
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1203-6. PubMed ID: 17666845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents.
    Muela S; Escalera B; Peña MA; Bustamante P
    Int J Pharm; 2010 Jan; 384(1-2):93-9. PubMed ID: 19819314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deviations of drug solubility in water-cosolvent mixtures from the Jouyban-Acree model--effect of solute structure.
    Jouyban A; Fakhree MA; Ghafourian T; Saei AA; Acree WE
    Pharmazie; 2008 Feb; 63(2):113-21. PubMed ID: 18380397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubility of organic solutes in ethanol/water mixtures.
    Li A; Yalkowsky SH
    J Pharm Sci; 1994 Dec; 83(12):1735-40. PubMed ID: 7891303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cosolvents on the binding interaction between poly(ethylene oxide) and sodium dodecyl sulfate.
    Dai S; Tam KC
    J Phys Chem B; 2006 Oct; 110(42):20794-800. PubMed ID: 17048889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubility enhancement of Cox-2 inhibitors using various solvent systems.
    Seedher N; Bhatia S
    AAPS PharmSciTech; 2003; 4(3):E33. PubMed ID: 14621965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenobarbital solubility in propylene glycol-glycerol-water systems.
    Moustafa MA; Molokhia AM; Gouda MW
    J Pharm Sci; 1981 Oct; 70(10):1172-4. PubMed ID: 7299657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-2-pyrrolidone as a cosolvent: relationship of cosolvent effect with solute polarity and the presence of proton-donating groups on model drug compounds.
    Tarantino R; Bishop E; Chen FC; Iqbal K; Malick AW
    J Pharm Sci; 1994 Sep; 83(9):1213-6. PubMed ID: 7830233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A statistical experimental approach to cosolvent formulation of a water-insoluble drug.
    Stephens D; Li LC; Pec E; Robinson D
    Drug Dev Ind Pharm; 1999 Aug; 25(8):961-5. PubMed ID: 10434141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solvent effects on chemical processes. 10. Solubility of alpha-cyclodextrin in binary aqueous-organic solvents: relationship to solid phase composition.
    Leiterman RV; Mulski MJ; Connors KA
    J Pharm Sci; 1995 Nov; 84(11):1272-5. PubMed ID: 8587041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.